irinotecan,bevacizumab
roche
['bevacizumab', 'rectal', 'irinotecan', 'crcsm', 'colorectal', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
. s dr. patrick boland &amp; colleagues present phase ii study of biweekly tas-102, irinotecan and bevacizumab in pre-treated metastatic #colorectal cancer (tabasco). at #asco23 #ascodailynews #crcsm 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.